1. Home
  2. INCR vs ICCC Comparison

INCR vs ICCC Comparison

Compare INCR & ICCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intercure Ltd.

INCR

Intercure Ltd.

HOLD

Current Price

$0.77

Market Cap

50.4M

Sector

Health Care

ML Signal

HOLD

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$6.06

Market Cap

55.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
INCR
ICCC
Founded
1994
1982
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.4M
55.5M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
INCR
ICCC
Price
$0.77
$6.06
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
47.3K
11.6K
Earning Date
03-30-2026
03-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
65.33
EPS
N/A
0.20
Revenue
N/A
$26,493,169.00
Revenue This Year
$69.54
N/A
Revenue Next Year
$41.75
N/A
P/E Ratio
N/A
$30.20
Revenue Growth
N/A
51.64
52 Week Low
$0.68
$4.52
52 Week High
$1.77
$7.60

Technical Indicators

Market Signals
Indicator
INCR
ICCC
Relative Strength Index (RSI) 32.81 46.64
Support Level $0.68 $6.06
Resistance Level $0.88 $6.85
Average True Range (ATR) 0.03 0.21
MACD -0.00 -0.05
Stochastic Oscillator 24.29 38.01

Price Performance

Historical Comparison
INCR
ICCC

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

Share on Social Networks: